Driving reinvestment in R&D for antibiotics and advocating their responsible use

News

Chatham House and Big Innovation Centre release research report on business model options for antibiotics

Business model options for antibiotics: learning from other industries Chatham House and Big Innovation Centre have released a research report offering a number of innovative models and ideas that address many of the critical questions facing policy-makers in the EU and the US as they seek solutions to the misalignment between the need for new antimicrobials and the incentives, or lack thereof, for their development. Released on February 24, 2015. Authors: E. Jaczynska, K. Outterson, and J. Mestre-Ferrandiz...
Read more

Université de Lorraine offers research fellowship with DRIVE-AB

The University of Lorraine in Nancy, France, is offering a full-time one-year research fellowship position under the supervision of Professor Céline Pulcini, MD, PhD, to work with Work Package 1A of DRIVE-AB. The aim of the research project is to define a framework for antibiotic stewardship using a variety of methods, such as systematic literature search, surveys, interviews, and focus groups. The position starts October 1, 2015, and is for one year. For more information and to apply, please click the link below to view the full job offer: Research Fellowship at Université de Lorraine  ...
Read more

Media reports following launch of DRIVE-AB

Read more

DRIVE-AB KICK START MEETING

Geneva, Switzerland, Monday 6th October 2014 - DRIVE-AB (Driving Reinvestment in R&D and Responsible Antibiotic Use), a public-private consortium funded by the EU Innovative Medicines Initiative (IMI), was delighted to hold its inaugural meeting which announced the launch of a €9.3million project to tackle the dual crisis of antimicrobial resistance and re-stimulate Pharma interest in antibiotic research and development. Antimicrobial resistance (AMR). Through a series of plenary discussions and break out sessions the expert consortium looked at work plans for delivering new economic models for antibiotic discovery and development and evaluation of the responsible use of new and old...
Read more

European Commission announces award of €1 million prize on Diagnostics: Reducing the Mis-use of Antibiotics Prize

The European Commission has announced the launch, in 2015, of a new €1 million prize on Diagnostics: Reducing the Mis-use of Antibiotics Prize. The Prize will reward a rapid test that can identify at the point of care patients with upper respiratory tract infections that can be managed safely without antibiotics. Awarded under the European Commission Horizon 2020 prize programme, this award is a different, but complementary initiative, to the £10 million Longitude Prize 2014 for Antibiotics that was launched on the 6th October....
Read more